Summary
                        
        
                            Upon availability of clinical trial data that would allow further evaluation of the developed vaccine candidates in Phase II clinical trials RBDCOV will organise a meeting with the VACCELERATE project InfoVaccelerateEU to present their findings and seek advice on how to best make use of existing clinical trial infrastructure developed in the VACCELERATE project VaccelerateEU to accelerate further clinical development of the vaccine candidates
                    
    
        
                                 
                    More information & hyperlinks
                        
         
                             
                             
                            